Haematopoietic stem cell donor registries: World Marrow Donor Association recommendations for evaluation of donor health
- PMID: 18362904
- DOI: 10.1038/bmt.2008.76
Haematopoietic stem cell donor registries: World Marrow Donor Association recommendations for evaluation of donor health
Abstract
The ability to identify unrelated haematopoietic stem cell donors in one country for recipients in another country requires cooperation and standardization in many areas. The donor assessment and testing are very important issues affecting quality and safety of donation. This special report details the World Marrow Donor Association's recommended procedures regarding the medical evaluation of donors, with the intent to protect the volunteer from the risk to damage his health and to offer the recipient the appropriate quality of stem cells. This document describes criteria for permanent or temporary deferral, guidelines for risk evaluation of infectious disease, examples of conditions requiring assessment and questionnaires designed to elicit relevant information about a donor's medical history and general health.
Similar articles
-
A special report: suggested procedures for international unrelated donor search from the donor registries and quality assurance working groups of the World Marrow Donor Association (WMDA).Bone Marrow Transplant. 2004 Jul;34(2):97-101. doi: 10.1038/sj.bmt.1704541. Bone Marrow Transplant. 2004. PMID: 15170174
-
Histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors: report from The World Marrow Donor Association. Quality Assurance and Donor Registries Working Groups of the World Marrow Donor Association.Bone Marrow Transplant. 1999 Jul;24(2):119-21. doi: 10.1038/sj.bmt.1701879. Bone Marrow Transplant. 1999. PMID: 10456664
-
World Marrow Donor Association: international standards for unrelated hematopoietic stem cell donor registries.Bone Marrow Transplant. 2004 Jul;34(2):103-10. doi: 10.1038/sj.bmt.1704542. Bone Marrow Transplant. 2004. PMID: 15170173
-
National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants.Biol Blood Marrow Transplant. 2008 Sep;14(9 Suppl):45-53. doi: 10.1016/j.bbmt.2008.06.014. Biol Blood Marrow Transplant. 2008. PMID: 18721780 Review. No abstract available.
-
Expanded criteria living donors: how far can we go?Prog Transplant. 2012 Jun;22(2):129-32; quiz 133. doi: 10.7182/pit2012244. Prog Transplant. 2012. PMID: 22878068 Review.
Cited by
-
Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee.Bone Marrow Transplant. 2014 Jul;49(7):880-6. doi: 10.1038/bmt.2014.67. Epub 2014 Apr 7. Bone Marrow Transplant. 2014. PMID: 24710563
-
Erythrocyte depletion from bone marrow: performance evaluation after 50 clinical-scale depletions with Spectra Optia BMC.J Transl Med. 2017 Aug 11;15(1):174. doi: 10.1186/s12967-017-1277-6. J Transl Med. 2017. PMID: 28800741 Free PMC article.
-
Donor Selection for Allogenic Hemopoietic Stem Cell Transplantation: Clinical and Ethical Considerations.Stem Cells Int. 2017;2017:5250790. doi: 10.1155/2017/5250790. Epub 2017 Jun 7. Stem Cells Int. 2017. PMID: 28680446 Free PMC article. Review.
-
Cell-Mediated Release of Nanoparticles as a Preferential Option for Future Treatment of Melanoma.Cancers (Basel). 2020 Jul 2;12(7):1771. doi: 10.3390/cancers12071771. Cancers (Basel). 2020. PMID: 32630815 Free PMC article. Review.
-
The Relationship between the Lifestyle of the Allogeneic Stem Cell Donors and the Number of Donated CD34+ and CD3+ Cells.Int J Hematol Oncol Stem Cell Res. 2024 Jul 1;18(3):210-219. doi: 10.18502/ijhoscr.v18i3.16101. Int J Hematol Oncol Stem Cell Res. 2024. PMID: 39257707 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical